申请人:Sterling Wintrop Inc.
公开号:US05290789A1
公开(公告)日:1994-03-01
The invention is related to compounds, being useful in treating psychosis, of the formula: ##STR1## wherein: R.sup.1 is hydrogen, lower-alkyl or phenyl-lower-alkyl; R.sup.2 and R.sup.4 are the same or different lower-alkyl; R.sup.3 is hydrogen or lower-alkyl; m is two or three; n is an integer from zero to three; and R.sup.5 is hydrogen, lower-alkyl, C.sub.3 -C.sub.7 -monocyclic cycloalkyl, allyl, or propargyl; or a pharmaceutically acceptable acid-addition salt thereof.
这项发明涉及一种化合物,用于治疗精神病,其化学式为:##STR1## 其中:R.sup.1为氢、较低烷基或苯基-较低烷基;R.sup.2和R.sup.4为相同或不同的较低烷基;R.sup.3为氢或较低烷基;m为二或三;n为0到3之间的整数;R.sup.5为氢、较低烷基、C.sub.3 -C.sub.7 单环脂环烷基、烯丙基或丙炔基;或其药学上可接受的酸加合盐。